Table 2.
Cardiovascular risk factors after treatment in successful H.pylori eradicated patients in the three groups
| Standard triple therapy (n = 25) | Broccoli sprouts powder (n = 14) | Standard triple therapy + Broccoli sprouts powder (n = 22) | p for treatment effect a | |
|---|---|---|---|---|
| Systolic blood pressure (mmHg) |
126 ± 4 |
122 ± 5 |
120 ± 4 |
0.63 |
| Diastolic blood pressure (mmHg) |
81 ± 3 |
78 ± 3 |
77 ± 3 |
0.68 |
| Total cholesterol (mg/dl) |
166 ± 8 |
156 ± 13 |
166 ± 8 |
0.82 |
| Triglycerides (mg/dl) |
154 ± 14 |
99 ± 29b |
118 ± 15b |
0.05 |
| HDL-cholesterol (mg/dl) |
29.0 ± 0.6 |
28.7 ± 1.1 |
29.0 ± 0.7 |
0.96 |
| LDL-cholesterol (mg/dl) |
108 ± 6 |
108 ± 10 |
114 ± 7 |
0.76 |
| Triglycerides/HDL-C |
5.5 ± 0.6 |
3.4 ± 1.1 |
4.2 ± 0.7 |
0.08 |
| Total cholesterol/HDL-C |
5.8 ± 0.3 |
5.5 ± 0.5 |
5.7 ± 0.3 |
0.88 |
| LDL-C/HDL-C |
3.8 ± 0.2 |
3.8 ± 0.4 |
4.0 ± 0.2 |
0.75 |
| hs-CRP (mg/l) | 2.9 ± 0.5 | 2.3 ± 0.8 | 2.7 ± 0.5 | 0.08 |
All values are mean (estimated marginal means based on baseline values as covariate in general linear model) ± SE.
aCalculated by using a general linear model with after treatment values as dependent variables, baseline values as covariates and treatment group as a fixed factor.
bSignificantly different from STT groups (Bonferroni pairwise comparison was used; P < 0.05).